You have read all your free articles, to continue reading subscribe to read the rest of this content.
Calliditas Therapeutics announced in July that the European Commission (EC) has granted conditional marketing authorization for Kinpeygo for the treatment of primary immunoglobulin A (IgA) nephropathy (IgAN) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (UPCAlready a subscriber Login You have read all your free…
The Board of Directors of the company has appointed Monica Shaw as Chief Executive Officer, CEO, of Oncopeptides. Shaw replaces Jakob Lindberg, who has been the CEO since November 15, 2021. Lindberg assumes his previous position as Chief Scientific Officer. A transformational year The leadershiAlready a subscriber Login You have…
Bavarian Nordic has announced that the European Medicines Agency (EMA) has granted access to its priority medicines (PRIME) scheme for MVA-BN RSV in active immunization for the prevention of lower respiratory tract disease (LRTD) caused by Respiratory Syncytial Virus (RSV) in adults ≥60 years of aAlready a subscriber Login You…
Meda has signed an agreement to divest the manufacturing unit in Lakewood, New Jersey. The manufacturing unit will be divested to the contract manufacturer DPT. According to Meda the manufacturing facility is dedicated to global supply of the product MUSE. As part of the agreement Meda has enAlready a subscriber Login…
